People

Julie Kim

Julie Kim became Takeda President, CEO and Representative Director on 24 June 2026. She joined through the Shire acquisition in 2019 and previously led the plasma-derived therapies and US business units. Earlier experience includes Baxter, Baxalta and Shire. She holds a Kellogg MBA and Dartmouth economics degree.